These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 27377780)
1. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance. Engelman R; Ziv T; Arnér ESJ; Benhar M Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780 [TBL] [Abstract][Full Text] [Related]
2. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416 [TBL] [Abstract][Full Text] [Related]
3. S-nitrosocysteine and glutathione depletion synergize to induce cell death in human tumor cells: Insights into the redox and cytotoxic mechanisms. Knany A; Engelman R; Hariri HA; Biswal S; Wolfenson H; Benhar M Free Radic Biol Med; 2020 Nov; 160():566-574. PubMed ID: 32898624 [TBL] [Abstract][Full Text] [Related]
4. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1. Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724 [TBL] [Abstract][Full Text] [Related]
5. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent. Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352 [TBL] [Abstract][Full Text] [Related]
6. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. Du Y; Zhang H; Lu J; Holmgren A J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247 [TBL] [Abstract][Full Text] [Related]
7. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities. Xu J; Cheng Q; Arnér ES Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501 [TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase. Pader I; Sengupta R; Cebula M; Xu J; Lundberg JO; Holmgren A; Johansson K; Arnér ES Proc Natl Acad Sci U S A; 2014 May; 111(19):6964-9. PubMed ID: 24778250 [TBL] [Abstract][Full Text] [Related]
9. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase. Peng X; Xu J; Arnér ES Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin. Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832 [TBL] [Abstract][Full Text] [Related]
11. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors. Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426 [TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of nitrosative stress: protein S-oxidation accompanies S-nitrosylation. Wang YT; Piyankarage SC; Williams DL; Thatcher GR ACS Chem Biol; 2014 Mar; 9(3):821-30. PubMed ID: 24397869 [TBL] [Abstract][Full Text] [Related]
13. Thioredoxin Reductase Inhibition for Cancer Therapy. Gencheva R; Arnér ESJ Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246 [TBL] [Abstract][Full Text] [Related]
14. TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Cebula M; Schmidt EE; Arnér ES Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897 [TBL] [Abstract][Full Text] [Related]
15. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. Anestål K; Arnér ES J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions. Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456 [TBL] [Abstract][Full Text] [Related]
19. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase. Xu J; Arnér ES Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931 [TBL] [Abstract][Full Text] [Related]
20. The role of thioredoxin in the regulation of cellular processes by S-nitrosylation. Sengupta R; Holmgren A Biochim Biophys Acta; 2012 Jun; 1820(6):689-700. PubMed ID: 21878369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]